Portland, OR -- (SBWIRE) -- 07/31/2017 -- Diabetes care devices helps in the management of blood glucose levels caused in patients due to inadequate insulin production or insulin resistance. The Diabetes Care Devices Market in Brazil, Russia, India and China (BRIC) nations is largely driven by the increasing incidence of diabetics across BRIC countries, especially among obese population, increased R&D activities on diabetes, along with increasing collaborations and funding to support diabetes research. However, exorbitant cost of availing diabetes care devices, irregular reimbursement, presence of cost-effective alternative treatments, and lack of diabetic care awareness may hinder the growth of the market.

Get full summary of the Report: https://www.alliedmarketresearch.com/diabetes-care-devices-market

Large untapped market has great potential for the growth of diabetes care devices coupled with favorable government policies are factors that create growth opportunities in this market. Pricing pressure faced by global players is a key market challenge.

Key market players are Becton, Dickinson and Company (U.S.), Roche Diagnostics Ltd. (Switzerland), Johnson and Johnson (U.S.), Bayer AG (Germany), Abbott Laboratories (U.S.), Acon Laboratories, Inc. (U.S.), Ypsomed AG (Switzerland), Novo Nordisk A/S (Denmark), Medtronic plc (Ireland), ARKRAY Inc. (Japan), Terumo Corporation (Japan), Dexcom, Inc. (U.S.), and Sanofi (France).

Get sample of the Report: https://www.alliedmarketresearch.com/request-toc-and-sample/1039

KEY MARKET SEGMENTS:

By Type

- Blood Glucose Monitoring Devices
- Testing Strips
- Self-monitoring Blood Glucose Meters
- Lancets
- Continuous Glucose Monitors
- Others

- Insulin Delivery Devices
- Insulin Syringes
- Insulin Pens
- Insulin Pumps
- Insulin Jet Injectors

By Country

- Brazil
- Russia
- China
- India

Prominent Market Player

- Becton, Dickinson and Company (U.S.)
- Roche Diagnostics Ltd. (Switzerland)
- Johnson and Johnson (U.S.)
- Bayer AG (Germany)
- Abbott Laboratories (U.S.)
- Acon Laboratories, Inc. (U.S.)
- Ypsomed AG (Switzerland)
- Novo Nordisk A/S (Denmark)
- Medtronic Plc. (Ireland)
- ARKRAY Inc. (Japan)
- Terumo Corporation (Japan)
- Dexcom, Inc. (U.S.)
- Sanofi (France).